Founded 2019
Founder Will Moss, CEO, Opvia

Opvia reduce the time taken to develop bio-processes by 10X, while increasing product quality and enabling reduced production costs. They achieve this by offering a platform which combines non-invasive in situ data acquisition with proprietary models and ML. Advanced therapeutics such as cell and gene therapies will provide cures to currently incurable diseases, and synthetic biology will revolutionise industrial manufacturing, energy and food production.

However, the cost of production is preventing these technologies from reaching scale. Opvia are positioned to enable the biotech revolution.


Founder

Will
Moss

CEO, Opvia

Data scientist and Chemical Engineering and Biotechnology graduate

Related

A&B Smart Materials

A&B Smart Materials

Revolutionising cooling technology through the development of novel, smart hydrogels.
AarogyaAI

AarogyaAI

AarogyaAI is an AI-enabled SaaS that diagnoses drug-resistant turberculosis (DR-TB) in hours instead of weeks.
AccuRx

AccuRx

Powering communications in the healthcare sector.
Ackcio

Ackcio

Extremely reliable, wireless monitoring solutions for the world's most challenging industries.
Adelántalo

Adelántalo

Factoring 2.0 for Trucking in LATAM.
Affable

Affable

Leverage AI for your Influencer Marketing Campaigns.